SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Second Sight Medical Products, Inc. (NasdaqGS – EYES)

BALA CYNWYD – June 23, 2020 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Second Sight Medical Products, Inc. (“Second Sight” or the “Company”) (NasdaqGS – EYES) for possible breaches of fiduciary duty and other violations of state law.

Call: 877-534-2590. There is no cost or obligation to you.

The investigation concerns whether the Second Sight Board failed to comply with state law and whether that failure to comply contributed to a reduction in share value. For example, on June 22, 2020, the stock closed at $1.09 and is trading well below the 52-week high of $8.96.

If you own shares of Second Sight stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or call toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.